Medical Xpress28 天
RAD51 testing shows promise in personalized early breast cancer treatment
Developed in-house by Serra's laboratory, a test based on the detection of the RAD51 protein as a functional biomarker of homologous recombination repair (HRR) is currently being validated in the ...
EurekAlert!28 天
The promise of RAD51 testing in tailoring treatment strategies in early breast cancer
Developed in-house by Serra’s laboratory, a test based on the detection of the RAD51 protein as a functional biomarker of homologous recombination repair (HRR) is currently being validated in ...